Shandong Pharmaceutical Glass Co Ltd (600529) — Capital Reinvestment Ratio
Shandong Pharmaceutical Glass Co Ltd (600529) has a Capital Reinvestment Ratio of 3.69x as of December 2025, meaning it reinvests 4% of its operating cash flow (CN¥41.46 Million) in capital expenditures (CN¥153.18 Million). See Shandong Pharmaceutical Glass Co Ltd (600529) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Pharmaceutical Glass Co Ltd Capital Reinvestment Ratio (2001–2025)
This chart tracks Shandong Pharmaceutical Glass Co Ltd's Capital Reinvestment Ratio across 24 annual periods. Check how aggressively does Shandong Pharmaceutical Glass Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shandong Pharmaceutical Glass Co Ltd (2001–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Pharmaceutical Glass Co Ltd from 2001 to 2025. For live market cap and broader valuation context, see Shandong Pharmaceutical Glass Co Ltd (600529) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.40x | CN¥576.92 Million | CN¥231.86 Million | ▼ -27.7% |
| 2024 | 0.56x | CN¥1.17 Billion | CN¥647.79 Million | ▼ -13.2% |
| 2023 | 0.64x | CN¥1.05 Billion | CN¥671.53 Million | ▼ -77.2% |
| 2022 | 2.82x | CN¥252.44 Million | CN¥710.71 Million | ▲ +161.1% |
| 2021 | 1.08x | CN¥750.44 Million | CN¥809.26 Million | ▲ +14.0% |
| 2020 | 0.95x | CN¥566.01 Million | CN¥535.20 Million | ▼ -4.3% |
| 2019 | 0.99x | CN¥599.05 Million | CN¥591.69 Million | ▲ +32.4% |
| 2018 | 0.75x | CN¥465.77 Million | CN¥347.38 Million | ▲ +83.9% |
| 2017 | 0.41x | CN¥411.96 Million | CN¥167.06 Million | ▲ +4.5% |
| 2016 | 0.39x | CN¥506.53 Million | CN¥196.58 Million | ▼ -2.5% |
| 2015 | 0.40x | CN¥389.63 Million | CN¥155.12 Million | ▼ -20.5% |
| 2014 | 0.50x | CN¥266.63 Million | CN¥133.53 Million | ▼ -10.6% |
| 2013 | 0.56x | CN¥268.60 Million | CN¥150.49 Million | ▼ -86.9% |
| 2012 | 4.28x | CN¥28.52 Million | CN¥122.10 Million | ▲ +440.5% |
| 2011 | 0.79x | CN¥274.63 Million | CN¥217.53 Million | ▼ -14.2% |
| 2010 | 0.92x | CN¥217.01 Million | CN¥200.37 Million | ▲ +94.3% |
| 2009 | 0.48x | CN¥249.27 Million | CN¥118.44 Million | ▼ -72.5% |
| 2008 | 1.73x | CN¥91.76 Million | CN¥158.40 Million | ▲ +31.6% |
| 2007 | 1.31x | CN¥122.63 Million | CN¥160.82 Million | ▲ +45.8% |
| 2006 | 0.90x | CN¥78.47 Million | CN¥70.59 Million | ▼ -53.4% |
| 2005 | 1.93x | CN¥44.09 Million | CN¥85.09 Million | ▼ -57.8% |
| 2003 | 4.58x | CN¥59.35 Million | CN¥271.74 Million | ▲ +344.7% |
| 2002 | 1.03x | CN¥109.26 Million | CN¥112.49 Million | ▲ +16.3% |
| 2001 | 0.89x | CN¥28.60 Million | CN¥25.32 Million | — |